S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TEVA Teva Pharmaceutical Industries Ltd

21.45

0.21 (0.99%)

Pre Market

Last Updated: 01:23:41

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Teva Pharmaceutical Indu... Charts.

Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Teva Pharmaceutical Indu... Charts.

Teva Pharmaceutical Industries Ltd News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 24 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
Saturday 21 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
Tuesday 17 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
Thursday 12 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
Friday 6 December 2024 (1 month ago) • GlobeNewswire Inc.

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
Wednesday 4 December 2024 (1 month ago) • GlobeNewswire Inc.

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
Tuesday 26 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Teva to Present at the Jefferies London Healthcare Conference
Saturday 9 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

More Teva Pharmaceutical Industries Ltd News Articles

FIL Fund Management Irel...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions